
Sign up to save your podcasts
Or


The Chinese AI company doesn’t want to bother with funding—at least not right now. WSJ reporter Rebecca Feng discusses why DeepSeek is so hesitant. Plus, how will federal funding cuts impact drug development? WSJ enterprise technology bureau chief Steven Rosenbush explains the impact on the bioscience industry. Shara Tibken hosts.
Sign up for the WSJ's free Technology newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal4.3
15771,577 ratings
The Chinese AI company doesn’t want to bother with funding—at least not right now. WSJ reporter Rebecca Feng discusses why DeepSeek is so hesitant. Plus, how will federal funding cuts impact drug development? WSJ enterprise technology bureau chief Steven Rosenbush explains the impact on the bioscience industry. Shara Tibken hosts.
Sign up for the WSJ's free Technology newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2,830 Listeners

1,719 Listeners

4,356 Listeners

411 Listeners

425 Listeners

672 Listeners

1,449 Listeners

1,037 Listeners

41 Listeners

1,298 Listeners

6,084 Listeners

69 Listeners

1,549 Listeners

1,322 Listeners

607 Listeners

151 Listeners

60 Listeners

145 Listeners